What did @justagrownwoman actually say?
She's making a pretty specific argument: if BPC-157 is upsetting your stomach, the peptide probably isn't the problem. Your diet is. Her core claim is that eating inflammatory or processed food while taking BPC-157 creates a conflict, where the peptide is trying to support gut repair while you're simultaneously triggering inflammation through what you eat. She recommends an AIP (autoimmune protocol) diet during any peptide course, especially for people with autoimmune conditions, and suggests taking a break from BPC-157 for a few days if GI distress occurs.
She doesn't cite any studies. She speaks from what sounds like clinical or personal experience with clients. She frames this as common sense lifestyle advice rather than a medical protocol, which is worth keeping in mind when we evaluate it.
Does the science back this up?
Partially, but not as cleanly as she implies. The claim that diet affects gut inflammation is well-supported. The claim that dietary inflammation would specifically blunt or conflict with BPC-157's effects is plausible but not directly tested in humans.
BPC-157 is a synthetic pentadecapeptide derived from a protein found in gastric juice. Animal studies, including work by Sikiric et al. (2018, Current Pharmaceutical Design), have shown it promotes healing of gastric ulcers, reduces intestinal inflammation, and modulates nitric oxide pathways in gut tissue. These are real findings, but they come almost entirely from rodent models. Human clinical trial data on BPC-157 is extremely limited as of 2024.
The AIP diet has been studied in small human trials. Konijeti et al. (2017, Inflammatory Bowel Diseases) found a 6-week AIP intervention reduced symptoms and inflammatory markers in patients with Crohn's disease. That's relevant context, even if it wasn't studied alongside peptides.
The specific mechanism she's describing, where a bad diet actively cancels out BPC-157's gut effects, hasn't been demonstrated in any published research. That gap matters.
What did they get wrong (or right)?
She gets the general direction right. Eating a pro-inflammatory diet while trying to support gut healing is counterproductive. That's not controversial. Telling people to watch what they eat during any therapeutic intervention is reasonable advice, not misinformation.
Where she oversimplifies: her framing that stomach upset from BPC-157 is mostly a diet problem is a bit too confident. There are other plausible explanations for GI side effects, including the route of administration, dosing, individual histamine sensitivity, and the fact that oral BPC-157 has highly variable bioavailability depending on preparation and formulation. She doesn't address any of that.
She also uses the phrase "autoimmune responses like crazy" loosely. Dietary triggers can provoke immune responses in the gut, but calling fast food a driver of autoimmune flares without qualification is imprecise. In someone with an actual autoimmune condition, yes, diet can influence disease activity. In a healthy person, the framing is an overstatement.
Her suggestion to pause BPC-157 for a few days if it causes distress is reasonable harm-reduction advice. That part lands fine.
What should you actually know?
BPC-157 has a genuinely interesting preclinical profile for gut repair, but it is not FDA-approved, and compounded versions vary significantly in quality and concentration. If you're experiencing GI distress while using it, diet is one possible factor among several worth investigating, not automatically the cause.
The AIP diet is a legitimate dietary framework with some evidence behind it for inflammatory gut conditions, but it is restrictive, and starting both an elimination diet and a new peptide at the same time makes it harder to know what's actually helping or hurting.
If you have an autoimmune condition specifically, the interaction between peptide therapy and your existing treatment plan should involve your prescribing physician, not a TikTok adjustment to your meal prep. This creator isn't wrong to point toward diet, but the confidence with which she attributes GI side effects to food choices is not backed by controlled human data on BPC-157 specifically.
Anyone using peptides through a regulated telehealth platform should report GI side effects to their provider rather than self-adjusting based on social media guidance, even well-intentioned guidance like this.